cytarabine Archives - Medical Conferences

No survival benefit of CPX-351 over FLAG-Ida in AML patients with adverse cytogenetics

Presented By

Prof. Nigel Russell, Guy's and St Thomas' NHS Foundation Trust, UK

Trial

Phase 3, AML19

Conference

EHA 2022

1 July, 2022 11:49

Presented By

Dr Justin Grenet, Weill Cornell Medical Center, NY, USA

Conference

ASH 2021

4 February, 2022 11:51

Presented By

Dr Patrick Reville, MD Anderson Cancer Center, TX, USA

Trial

Phase 2

Conference

ASH 2021

4 February, 2022 11:48

Presented By

Prof. Nigel Russell, Guy's Hospital, UK

Trial

AML16; AML18

Conference

EHA 2021

5 August, 2021 13:55

Presented By

Dr Gerald Illerhaus, Klinikum der Landeshauptstadt Stuttgart, Germany

Trial

Phase 2, IELSG32

Conference

EHA 2021

5 August, 2021 12:05

Presented By

Dr Xiaowen Tang; Dr James Foran

Trial

Phase 2, ECOG-ACRIN E2906

Conference

ASH 2019

5 March, 2020 13:16